Deane Retirement Strategies Inc. Grows Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Deane Retirement Strategies Inc. raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 10,050 shares of the medical equipment provider’s stock after acquiring an additional 97 shares during the quarter. Intuitive Surgical makes up approximately 2.6% of Deane Retirement Strategies Inc.’s holdings, making the stock its 8th biggest position. Deane Retirement Strategies Inc.’s holdings in Intuitive Surgical were worth $5,246,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Berbice Capital Management LLC acquired a new position in Intuitive Surgical during the fourth quarter worth $26,000. Godsey & Gibb Inc. grew its position in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after acquiring an additional 35 shares during the period. MidAtlantic Capital Management Inc. acquired a new position in shares of Intuitive Surgical during the 3rd quarter worth about $33,000. Decker Retirement Planning Inc. bought a new stake in shares of Intuitive Surgical in the 4th quarter valued at about $36,000. Finally, Capital Performance Advisors LLP acquired a new stake in Intuitive Surgical in the 3rd quarter valued at about $38,000. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Trading Up 0.1 %

Shares of Intuitive Surgical stock opened at $574.14 on Wednesday. The company has a market cap of $204.50 billion, a PE ratio of 92.31, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39. The company has a 50 day moving average of $548.00 and a 200-day moving average of $506.12. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00.

Insiders Place Their Bets

In other news, Director Amal M. Johnson sold 4,635 shares of the stock in a transaction dated Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the completion of the transaction, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This represents a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 108 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 28,749 shares of company stock worth $15,303,875 over the last three months. Insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

Several analysts have issued reports on the company. Robert W. Baird upped their price objective on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research note on Thursday, October 17th. Wells Fargo & Company increased their price target on Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research note on Friday, January 24th. Evercore ISI lifted their price objective on shares of Intuitive Surgical from $490.00 to $530.00 in a research report on Monday. Piper Sandler reissued an “overweight” rating and issued a $670.00 price objective (up from $538.00) on shares of Intuitive Surgical in a research report on Friday, January 24th. Finally, Jefferies Financial Group lifted their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.